Medicines Co (MDCO) Tops Q4 EPS by 28c

Medicines Co (NASDAQ: MDCO) reported Q4 EPS of $0.52, $0.28 better than the analyst estimate of $0.24. Revenue for the quarter came in at $132.2 million versus the consensus estimate of $124.99 million.

For earnings history and earnings-related data on Medicines Co (MDCO) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat